Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 201

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 201
---
. If the carrying value of a reporting unit exceeds its fair value, the Company recognizes an
impairment of goodwill for the amount of this excess.

The Company
will perform the quantitative goodwill impairment test during the fourth quarter of each fiscal year, or more frequently if impairment
indicators are present and compares the fair value of the reporting unit with its carrying value.

During the period commencing July
23, 2024 through December 31, 2024, no goodwill impairment losses have been identified.

| r. | Accounting pronouncement recently 
 adopted                           |

In November
2023, the FASB issued ASU 2023-07, “Improvements to Reportable Segment Disclosures (Topic 280)” which requires enhanced disclosure
of (1) significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit
or loss, (2) the amount and description of the composition of other segment items which reconcile to segment profit or loss, and (3)
the title and position of the entity’s CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or
loss in assessing segment performance and allocating resources. The amendments also expand the interim segment disclosure requirements.
This new guidance is effective for annual periods beginning October 1, 2024, and interim periods beginning October 1, 2025. Early adoption
is permitted. The Company has adopted this standard for the fiscal year 2024 annual financial statements and interim financial statements
thereafter and has applied this standard retrospectively for all prior periods presented in the financial statements. See Note 12
– Segment Reporting for further information.

| s. | Recently issued accounting pronouncements 
 not yet adopted                           |

In December
2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures, which requires disaggregated information
about the effective tax rate reconciliation as well as information on income taxes paid. The guidance will be effective for the Company
for annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the impact on its financial
statement disclosures.

In November
2024, the FASB issued ASU 2024-03 “Income Statement (Topic 220): Reporting Comprehensive Income - Expense Disaggregation Disclosures” (“ASU
2024-03”), which requires more detailed information about specified categories of expenses presented on the face